PNC Financial Services Group Inc. boosted its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 3.3% during the 1st quarter, HoldingsChannel.com reports. The firm owned 82,950 shares of the company’s stock after purchasing an additional 2,621 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Cardinal Health were worth $17,528,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in CAH. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health in the fourth quarter valued at approximately $26,000. Jones Financial Companies Lllp raised its holdings in shares of Cardinal Health by 198.3% during the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock valued at $27,000 after buying an additional 14,034 shares in the last quarter. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health during the 4th quarter valued at about $27,000. Palladiem LLC bought a new stake in Cardinal Health in the 4th quarter worth approximately $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in shares of Cardinal Health in the 1st quarter valued at $29,000. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Cardinal Health Price Performance
Shares of NYSE CAH opened at $227.96 on Friday. The company’s 50-day moving average is $219.98 and its 200 day moving average is $214.43. The stock has a market capitalization of $53.39 billion, a P/E ratio of 34.86, a P/E/G ratio of 1.11 and a beta of 0.49. Cardinal Health, Inc. has a 1 year low of $137.75 and a 1 year high of $243.21.
Cardinal Health Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st were paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date was Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio (DPR) is 31.50%.
Analysts Set New Price Targets
Several analysts have issued reports on CAH shares. UBS Group upped their price target on shares of Cardinal Health from $260.00 to $274.00 and gave the company a “buy” rating in a research report on Monday. William Blair started coverage on Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating on the stock. Zacks Research cut Cardinal Health from a “strong-buy” rating to a “hold” rating in a report on Friday, June 12th. Citigroup raised their target price on shares of Cardinal Health from $245.00 to $265.00 and gave the stock a “buy” rating in a report on Friday. Finally, Bank of America raised their price target on shares of Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a report on Thursday, July 2nd. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $251.73.
Check Out Our Latest Research Report on CAH
Cardinal Health Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
- Five stocks we like better than Cardinal Health
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
